BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31126631)

  • 1. The role of doxycycline in the management of chronic rhinosinusitis with nasal polyps.
    Parasher AK; Kidwai SM; Konuthula N; Goljo E; Pan S; Saini AT; Del Signore A; Iloreta AM; Govindaraj S; Malkin BD
    Am J Otolaryngol; 2019; 40(4):467-472. PubMed ID: 31126631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
    Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
    J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline may be more clinically effective in type 2 chronic rhinosinusitis nasal polyp comorbid with asthma.
    Paçacı Çetin G; Arslan B; Yılmaz İ
    J Asthma; 2024 Jan; 61(1):20-26. PubMed ID: 37437223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline Improves Quality of Life and Anosmia in Chronic Rhinosinusitis With Nasal Polyposis: A Randomized Controlled Trial.
    Nabavi M; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Sabouri S; Moosavian F; Nazari J; Bakrani V; Atashrazm F
    Am J Rhinol Allergy; 2023 Jul; 37(4):384-390. PubMed ID: 36740870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral steroids and doxycycline: two different approaches to treat nasal polyps.
    Van Zele T; Gevaert P; Holtappels G; Beule A; Wormald PJ; Mayr S; Hens G; Hellings P; Ebbens FA; Fokkens W; Van Cauwenberge P; Bachert C
    J Allergy Clin Immunol; 2010 May; 125(5):1069-1076.e4. PubMed ID: 20451040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced sinonasal levels of 1α-hydroxylase are associated with worse quality of life in chronic rhinosinusitis with nasal polyps.
    Schlosser RJ; Carroll WW; Soler ZM; Pasquini WN; Mulligan JK
    Int Forum Allergy Rhinol; 2016 Jan; 6(1):58-65. PubMed ID: 26575398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
    Bachert C; Hellings PW; Mullol J; Hamilos DL; Gevaert P; Naclerio RM; Joish VN; Chao J; Mannent LP; Amin N; Abbe A; Taniou C; Fan C; Pirozzi G; Graham NMH; Mahajan P; Staudinger H; Khan A
    Allergy; 2020 Jan; 75(1):148-157. PubMed ID: 31306495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps.
    Pinto Bezerra Soter AC; Bezerra TF; Pezato R; Teles Abdo TR; Pilan RM; Pinna FR; Gevaert P; van Zele T; Bachert C; Voegels RL
    Rhinology; 2017 Jun; 55(2):175-180. PubMed ID: 28434014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant protein A and D in chronic rhinosinusitis with nasal polyposis and corticosteroid response.
    Salman S; Akpinar ME; Yigit O; Gormus U
    Am J Rhinol Allergy; 2012; 26(2):e76-80. PubMed ID: 22487281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
    Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
    J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of efficacy for combination oral and topical corticosteroids to treat patients with chronic rhinosinusitis with nasal polyps.
    Epperson MV; Phillips KM; Caradonna DS; Gray ST; Sedaghat AR
    Int Forum Allergy Rhinol; 2019 Dec; 9(12):1436-1442. PubMed ID: 31609091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic rhinosinusitis with nasal polyposis with oral steroids followed by topical steroids: a randomized trial.
    Vaidyanathan S; Barnes M; Williamson P; Hopkinson P; Donnan PT; Lipworth B
    Ann Intern Med; 2011 Mar; 154(5):293-302. PubMed ID: 21357906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
    Mullol J; Laidlaw TM; Bachert C; Mannent LP; Canonica GW; Han JK; Maspero JF; Picado C; Daizadeh N; Ortiz B; Li Y; Ruddy M; Laws E; Amin N
    Allergy; 2022 Apr; 77(4):1231-1244. PubMed ID: 34459002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of immediate postoperative systemic corticosteroids when utilizing a steroid-eluting spacer following sinus surgery.
    Dautremont JF; Mechor B; Rudmik L
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):689-95. PubMed ID: 24482348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery.
    Neubauer PD; Schwam ZG; Manes RP
    Int Forum Allergy Rhinol; 2016 Mar; 6(3):233-7. PubMed ID: 26679480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum amyloid A in nasal polyps is associated with systemic corticosteroid insensitivity in patients with chronic rhinosinusitis with nasal polyps: a pilot study.
    Lu H; Lin XS; Yao DM; Zhuang YY; Wen GF; Shi J; Sun YQ
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):401-408. PubMed ID: 29177948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and symptom criteria for the accurate diagnosis of chronic rhinosinusitis.
    Bhattacharyya N
    Laryngoscope; 2006 Jul; 116(7 Pt 2 Suppl 110):1-22. PubMed ID: 16826087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the Sino-Nasal Outcome Test 22 and visual analog scale symptom scores in chronic rhinosinusitis with and without nasal polyps.
    Gregurić T; Trkulja V; Baudoin T; Grgić M; Šmigovec I; Kalogjera L
    Am J Rhinol Allergy; 2016; 30(2):107-12. PubMed ID: 26980391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-33 Expression in Chronic Rhinosinusitis with Nasal Polyps and Its Relationship with Clinical Severity.
    Song W; Wang C; Zhou J; Pan S; Lin S
    ORL J Otorhinolaryngol Relat Spec; 2017; 79(6):323-330. PubMed ID: 29186722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.